2022 Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Raynier Devillier Journal Bone Marrow Transplant.
2022 Human leukocyte antigen-haploidentical transplantation for relapsed/refractory acute myeloid leukemia: Better leukemia-free survival with bone marrow than with peripheral blood stem cells in patients ≥55 years of age Group Acute Leukemia Working Party (ALWP) 1st listed author Frédéric Baron Journal Am J Hematol.
2022 Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia Group Acute Leukemia Working Party (ALWP) 1st listed author Justin Loke Journal Cancer.
2022 Impact of donor kinship on non-T-cell depleted haploidentical stem cell transplantation with post transplantation cyclophosphamide for acute leukemia: From the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Ivetta Danylesko Journal Bone Marrow Transplant.
2022 Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Bone Marrow Transplant.
2022 Augmented FLAMSA-Bu versus FluBu2 reduced-intensity conditioning in patients with active relapsed/refractory acute myeloid leukemia: an EBMT analysis Group Acute Leukemia Working Party (ALWP) 1st listed author Eduardo Rodríguez-Arbolí Journal Bone Marrow Transplant.
2022 Measurable residual disease, FLT3-ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1-mutated acute myeloid leukemia Group Acute Leukemia Working Party (ALWP) 1st listed author Rama Al Hamed Journal Cancer Med.
2022 Non-T depleted haploidentical stem cell transplantation in AML patients achieving first complete remission after one versus two induction courses: a study from the ALWP/EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Bone Marrow Transplant.
2022 Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia Group Acute Leukemia Working Party (ALWP) 1st listed author Christoph Schmid Journal Bone Marrow Transplant.
2022 The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AML Group Acute Leukemia Working Party (ALWP) 1st listed author Avichai Shimoni Journal Bone Marrow Transplant.
2022 Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Transplant Cell Ther.
2022 Extracorporeal membrane oxygenation in children receiving haematopoietic cell transplantation and immune effector cell therapy: an international and multidisciplinary consensus statement Group Paediatric Diseases Working Party (PDWP) Other society 1st listed author Matteo Di Nardo Journal Lancet Child Adolesc Health.